Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
BACK TO LIST

European Patient Summary

Patient
Name: Schofield, Suzanne
DOB: 12-OCT-1994 (Age: 31)
Gender: female
ID: 4094-408942-0 (ECI)
Author
dr Jones, Edward
Patient summary Document
European Patient Summary
Report Date: 06-OCT-2024

Problem list

Condition Onset Date / Period Status
Essential hypertension 06-Oct-2024 active
Metabolic syndrome X 06-Oct-2024 active
Hypertriglyceridemia 06-Oct-2024 active
Type 2 diabetes mellitus 03-Oct-2021 active
Anemia 27-Sep-2015 active
Recurrent urinary tract infection 22-Mar-2010 active
Miscarriage in first trimester 07-Apr-2024 - 26-Apr-2024 inactive
Blighted ovum 07-Apr-2024 - 26-Apr-2024 inactive
Concussion with no loss of consciousness 31-Jul-2021 - 11-Sep-2021 inactive
Concussion injury of brain 31-Jul-2021 - 11-Sep-2021 inactive
Acute bronchitis 28-Aug-2019 - 06-Sep-2019 inactive
Acute viral pharyngitis 11-Nov-2018 - 23-Nov-2018 inactive
Acute bronchitis 18-Oct-2015 - 26-Oct-2015 inactive

Medication list

Medication Since Form Dosage Reason
Lisinopril 10 mg oral tablet 2024-11-05 - 1 tablet (10 mg) by mouth once daily Essential hypertension (disorder)
Amlodipine (as amlodipine besylate) 2.5 mg oral tablet 2024-10-06 - 1 tablet (2.5 mg) by mouth once daily Essential hypertension (disorder)

Immunizations list

Vaccine Date
Clostridium tetani toxoid antigen adsorbed only vaccine product 06-Oct-2024
Influenza virus antigen only vaccine product 06-Oct-2024
SARS-CoV-2 mRNA vaccine 06-Jun-2021
Hepatitis B virus antigen only vaccine product 11-Oct-2015
Neisseria meningitidis antigen-containing vaccine product 27-Sep-2015

Procedure History list

Procedure Date Reason
Epidural anesthesia 29-May-2022 Normal pregnancy (finding)
Medical induction of labor 25-Oct-2020 Normal pregnancy (finding)

Allergies and Intolerances

No known allergies or intolerances

Care Plan

Active Planned Care / Goals Start Date Reason
Lifestyle education regarding hypertension 06-Oct-2024 Essential hypertension (disorder)
  • Achieve systolic blood pressure less than 130 mmHg through lifestyle modifications.
  • Achieve diastolic blood pressure less than 80 mmHg through lifestyle modifications.
Diabetes self management plan 27-Sep-2015 Prediabetes (finding)
  • Achieve and maintain HbA1c below 7% through lifestyle modification and medication adherence.
  • Lose at least 5% of baseline body weight to improve glycemic control and metabolic health.
  • Engage in at least 150 minutes of moderate-intensity aerobic activity per week.
  • Adopt a balanced diet with reduced intake of refined carbohydrates and saturated fats.
  • Self-monitor fasting blood glucose at least 3 times per week.

Vital Signs

Vital Signs 2025-03-05 2025-01-04
Blood pressure panel with all children optional 89 mm[Hg] 90 mm[Hg]

Relevant diagnostic tests/laboratory data

Recent Lab Observations 06-OCT-2024 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 7.1 H 4.8 - 5.6 %
Glucose [Mass/volume] in Blood 110.8 H 70 - 100 mg/dL
Urea nitrogen [Mass/volume] in Blood 15.3 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 1.0 0.5 - 1.2 mg/dL
Calcium [Mass/volume] in Blood 9.9 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 137.2 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.7 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 104.3 98 - 107 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 23.9 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 220.3 H 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 168.0 H 0 - 149 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 137.3 H 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 49.4 40 - 60 mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine 16.9 0 - 30 mg/g

Device Use

Device Date (since)
Blood glucose meter (physical object) 27-Sep-2015